Avycaz Dose Confusion Leads to FDA Medication Error Warning
The FDA is warning of potential dosing errors with the antibacterial medication Avycaz, and is requiring new label warnings to clarify dosing.
September 23, 2015 By: Russell Maas
The FDA is warning of potential dosing errors with the antibacterial medication Avycaz, and is requiring new label warnings to clarify dosing.
A federal judge has ordered the CEO of 3M Company to attend settlement negotiations over Combat Arms earplugs hearing loss litigation.
Plaintiffs have filed a Master Complaint in consolidated hair relaxer litigation, which will help make direct filing of cases to the MDL court easier.
A federal judge has ordered parties to sift through Paraquat lawsuits to identify cases which are unlikely to move forward based on patient deaths and implausible theories of proof.